Carl Zeiss Meditec AG
CZMWY · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.08 | -0.93 | -21.00 | 1.31 |
| FCF Yield | 5.06% | 1.51% | 1.85% | 1.12% |
| EV / EBITDA | 11.01 | 28.63 | 15.06 | 19.84 |
| Quality | ||||
| ROIC | 6.03% | 3.18% | 9.29% | 12.04% |
| Gross Margin | 52.76% | 52.69% | 57.71% | 59.26% |
| Cash Conversion Ratio | 1.63 | 1.37 | 0.86 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.16% | 2.78% | 8.26% | 12.53% |
| Free Cash Flow Growth | 97.86% | -30.57% | 28.97% | -64.18% |
| Safety | ||||
| Net Debt / EBITDA | 0.29 | 0.59 | 0.29 | 0.25 |
| Interest Coverage | 9.65 | 3.80 | 170.74 | 37.82 |
| Efficiency | ||||
| Inventory Turnover | 2.12 | 1.82 | 1.70 | 2.03 |
| Cash Conversion Cycle | 261.14 | 234.69 | 189.23 | 170.60 |